Categories: Business

UNCY Investors Have Opportunity to Join Unicycive Therapeutics, Inc. Fraud Investigation With the Schall Law Firm

LOS ANGELES–(BUSINESS WIRE)–$UNCYThe Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Unicycive Therapeutics, Inc. (“Unicycive” or “the Company”) (NASDAQ: UNCY) for violations of the securities laws.

- Advertisement -


- Advertisement -

The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. Unicycive announced on June 30, 2025, that the FDA “has issued a CRL [Complete Response Letter] for its New Drug Application (NDA) for OLC to treat hyperphosphatemia in patients with chronic kidney disease (CKD) on dialysis.” The Company added that “After submitting the NDA, and as a part of the application review and routine information requests, the FDA notified Unicycive that a third-party manufacturing vendor of its main contract development and manufacturing organization (CDMO) was cited for deficiencies following a cGMP inspection.” Based on this news, shares of Unicycive fell by 29.85% on the same day.

If you are a shareholder who suffered a loss, click here to participate.

- Advertisement -

We also encourage you to contact Brian Schall of the Schall Law Firm, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm’s website at www.schallfirm.com, or by email at bschall@schallfirm.com.

- Advertisement -

The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.

- Advertisement -

Contacts

- Advertisement -

The Schall Law Firm

Brian Schall, Esq.

310-301-3335

info@schallfirm.com
www.schallfirm.com

Business Wire

Recent Posts

Tescan Unveils New Global Brand Platform “The Art of Discovery” with APAC Rollout at SEMICON Taiwan

KARLSRUHE, Germany, BRNO, Czech Republic and TAIPEI, Sept. 1, 2025 /PRNewswire/ -- Tescan Group proudly introduces its…

49 minutes ago

Omya unveils sustainable innovations at K 2025: Spotlight on performance polymer materials, decarbonization and lightweighting

OFTRINGEN, Switzerland, Sept. 1, 2025 /PRNewswire/ -- Omya, a global producer of essential minerals and…

49 minutes ago

Nippon Life India Asset Management (NAM India) Strengthening Indo-Japan Ties: Sundeep Sikka

MUMBAI, India, Sept. 1, 2025 /PRNewswire/ -- Nippon Life India Asset Management CEO Represents India…

50 minutes ago

SPJIMR WISE Tech leads dialogue on sustainable consumption

84% of Indians prefer sustainable products, but an 'intent–action gap' remains MUMBAI, India, Sept. 1,…

50 minutes ago

Cytokinetics Presents New Data Related to Aficamten at the European Society of Cardiology Congress 2025

Additional Data from MAPLE-HCM Shows Aficamten Improves Cardiac Structure and Function Compared to Metoprolol; Simultaneous Publication in…

3 hours ago